Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020093003 - TUMOR HOMING CELL COMPOSITIONS FOR USE IN THERAPEUTIC METHODS

Publication Number WO/2020/093003
Publication Date 07.05.2020
International Application No. PCT/US2019/059532
International Filing Date 01.11.2019
IPC
A61B 5/055 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
BDIAGNOSIS; SURGERY; IDENTIFICATION
5Measuring for diagnostic purposes; Identification of persons
05Measuring for diagnosis by means of electric currents or magnetic fields
055involving electronic or nuclear magnetic resonance, e.g. magnetic resonance imaging
A61K 35/12 2015.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
A61K 35/28 2015.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
A61K 35/30 2015.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
30Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
A61K 38/43 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
43Enzymes; Proenzymes; Derivatives thereof
A61K 45/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
Applicants
  • FALCON THERAPEUTICS, INC. [US]/[US]
  • THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL [US]/[US]
Inventors
  • HINGTGEN, Shawn D.
  • NICHOLS, Susan B.
Agents
  • POULOS, Sabrina D.
Priority Data
62/754,44501.11.2018US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) TUMOR HOMING CELL COMPOSITIONS FOR USE IN THERAPEUTIC METHODS
(FR) COMPOSITIONS DE CELLULES D'ÉCOTROPISME DE TUMEUR DESTINÉES À ÊTRE UTILISÉES DANS DES MÉTHODES THÉRAPEUTIQUES
Abstract
(EN)
Provided herein are induced tumor-homing drug carrier cells for use in the treatment of ovarian cancer. Also described herein are pharmaceutical compositions comprising induced tumor-homing drug carrier cells for use in the treatment of ovarian cancer.
(FR)
La présente invention concerne des cellules vecteurs de médicament d'écotropisme de tumeur induite destinées à être utilisées dans le traitement du cancer de l'ovaire. L'invention concerne également des compositions pharmaceutiques comprenant des cellules vecteurs de médicament d'écotropisme de tumeur induite destinées à être utilisées dans le traitement du cancer de l'ovaire.
Latest bibliographic data on file with the International Bureau